Lazard Asset Management
WX

Lazard Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Lazard Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-101,561
Closed -$4.39M – 1186
2015
Q3 		$4.39M Buy
101,561
+30,410
+43% +$1.28M 0.01% 504
2015
Q2 		$3M Sell
71,151
-110,969
-61% -$4.68M 0.01% 591
2015
Q1 		$7.06M Buy
182,120
+134,547
+283% +$5.18M 0.02% 465
2014
Q4 		$1.6M Buy
47,573
+12,700
+36% +$449K ﹤0.01% 701
2014
Q3 		$1.22M Buy
34,873
+34,673
+17,337% +$1.19M ﹤0.01% 662
2014
Q2 		$6K Hold
200
– – ﹤0.01% 974
2014
Q1 		$7K Hold
200
– – ﹤0.01% 957
2013
Q4 		$7K Hold
200
– – ﹤0.01% 974
2013
Q3 		$5K Buy
+200
New +$4.74K ﹤0.01% 923

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Lazard Asset Management's WX Position: Q4 2015 in Review

Lazard Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 101,561 shares — an estimated $4.39M sold.

Lazard Asset Management first reported a position in WX in Q3 2013 and held it in 9 quarters. The position peaked at $7.06M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Lazard Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Lazard Asset Management sold 101,561 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.39M.
  • Lazard Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2013 and held it in 9 quarters.
  • Lazard Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.06M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Lazard Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.